"","submission_name","submission_date","template_name","tissue_type","response_component_original","response_comp_orig_cnt","response_component","response_comp_cnt","response_behavior_type","response_behavior","subgroup","time_point","time_point_units","baseline_time","comparison","target_pathogen","vaccine_year","exposure_material","additional_exposure_material","cohort","adjuvant","route","publication_reference","publication_year","signature_source","signature_source_url","comments","is_model","publication_reference_url","age_group","age_min","age_max","age_units","subm_obs_id","uniq_obs_id","row_key","signature_file","signature_file_complete"
"subject","","","","cell_subset","","","gene","","","","","","","","","pathogen","","vaccine","","","","","","","","","","","","","","","","","","","",""
"evidence","","","","","label","label","","label","label","label","label","label","label","label","label","","label","","label","label","label","label","label","label","label","label","label","label","url","label","label","label","label","label","label","label","file","file"
"role","","","","tissue","observed","observed","gene_biomarker","observed","background","measured","background","observed","observed","background","background","pathogen","background","vaccine","background","observed","background","background","background","background","background","background","background","background","reference","observed","observed","observed","observed","background","background","background","observed","observed"
"mime_type","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"numeric_units","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"display_text","","","","tissue type","response component (original gene symbol)","response component (original) count","response component (gene symbol)","response component count","response behavior type","response behavior","subgroup","time point","time point units","baseline time","comparison","target pathogen","vaccine year (influenza only)","exposure material (VO)","exposure material - additional","cohort","adjuvant","route","publication reference (PMID)","publication year","signature source figure, table or text section ","signature source url","comments and additional details","gene signature is a model","García-Piñeres et al. (2009) Gene expression patterns induced by HPV-16 L1 virus-like particles in leukocytes from vaccine recipients. J Immunol. PMID: <a href = 'https://www.ncbi.nlm.nih.gov/pubmed/?term=19155521' target='_blank'>19155521</a>","age group","age min.","age max.","age units","ID of observation within its own submission","Uniq ID of observation within its submission type","row key","response component (genes) file"," response components including non-HGNC genes"
"","hipc_gene_19155521_6","2009.02","hipc_gene_19155521_6","peripheral blood mononuclear cell","IMPA2","20","IMPA2","20","gene expression","negativelyly  correlated with","none","12","Months","time of vaccination (first dose)","antibody response","human Papillomavirus","","VO_0003156","","young adults (18-25)","","","19155521","2009","Suppl Table III","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701477/bin/NIHMS83712-supplement-Supplemetary_t.doc' target='_blank'>Supplemetary_t.doc</a>","Spearman Correlation of Gene Expression with Neutralizing Antibody Levels","N","https://www.ncbi.nlm.nih.gov/pubmed/?term=19155521","adults","18","25","years","6","161","19155521_6_161","hipc_gene_sig_19155521_6.txt","hipc_gene_sig_complete_19155521_6.txt"
"","hipc_gene_19155521_6","2009.02","hipc_gene_19155521_6","peripheral blood mononuclear cell","RBMS2","20","RBMS2","20","gene expression","negativelyly  correlated with","none","12","Months","time of vaccination (first dose)","antibody response","human Papillomavirus","","VO_0003156","","young adults (18-25)","","","19155521","2009","Suppl Table III","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701477/bin/NIHMS83712-supplement-Supplemetary_t.doc' target='_blank'>Supplemetary_t.doc</a>","Spearman Correlation of Gene Expression with Neutralizing Antibody Levels","N","https://www.ncbi.nlm.nih.gov/pubmed/?term=19155521","adults","18","25","years","6","161","19155521_6_161","hipc_gene_sig_19155521_6.txt","hipc_gene_sig_complete_19155521_6.txt"
"","hipc_gene_19155521_6","2009.02","hipc_gene_19155521_6","peripheral blood mononuclear cell","FUCA1","20","FUCA1","20","gene expression","negativelyly  correlated with","none","12","Months","time of vaccination (first dose)","antibody response","human Papillomavirus","","VO_0003156","","young adults (18-25)","","","19155521","2009","Suppl Table III","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701477/bin/NIHMS83712-supplement-Supplemetary_t.doc' target='_blank'>Supplemetary_t.doc</a>","Spearman Correlation of Gene Expression with Neutralizing Antibody Levels","N","https://www.ncbi.nlm.nih.gov/pubmed/?term=19155521","adults","18","25","years","6","161","19155521_6_161","hipc_gene_sig_19155521_6.txt","hipc_gene_sig_complete_19155521_6.txt"
"","hipc_gene_19155521_6","2009.02","hipc_gene_19155521_6","peripheral blood mononuclear cell","ADD3","20","ADD3","20","gene expression","negativelyly  correlated with","none","12","Months","time of vaccination (first dose)","antibody response","human Papillomavirus","","VO_0003156","","young adults (18-25)","","","19155521","2009","Suppl Table III","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701477/bin/NIHMS83712-supplement-Supplemetary_t.doc' target='_blank'>Supplemetary_t.doc</a>","Spearman Correlation of Gene Expression with Neutralizing Antibody Levels","N","https://www.ncbi.nlm.nih.gov/pubmed/?term=19155521","adults","18","25","years","6","161","19155521_6_161","hipc_gene_sig_19155521_6.txt","hipc_gene_sig_complete_19155521_6.txt"
"","hipc_gene_19155521_6","2009.02","hipc_gene_19155521_6","peripheral blood mononuclear cell","CXCL2","20","CXCL2","20","gene expression","negativelyly  correlated with","none","12","Months","time of vaccination (first dose)","antibody response","human Papillomavirus","","VO_0003156","","young adults (18-25)","","","19155521","2009","Suppl Table III","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701477/bin/NIHMS83712-supplement-Supplemetary_t.doc' target='_blank'>Supplemetary_t.doc</a>","Spearman Correlation of Gene Expression with Neutralizing Antibody Levels","N","https://www.ncbi.nlm.nih.gov/pubmed/?term=19155521","adults","18","25","years","6","161","19155521_6_161","hipc_gene_sig_19155521_6.txt","hipc_gene_sig_complete_19155521_6.txt"
"","hipc_gene_19155521_6","2009.02","hipc_gene_19155521_6","peripheral blood mononuclear cell","HS3ST2","20","HS3ST2","20","gene expression","negativelyly  correlated with","none","12","Months","time of vaccination (first dose)","antibody response","human Papillomavirus","","VO_0003156","","young adults (18-25)","","","19155521","2009","Suppl Table III","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701477/bin/NIHMS83712-supplement-Supplemetary_t.doc' target='_blank'>Supplemetary_t.doc</a>","Spearman Correlation of Gene Expression with Neutralizing Antibody Levels","N","https://www.ncbi.nlm.nih.gov/pubmed/?term=19155521","adults","18","25","years","6","161","19155521_6_161","hipc_gene_sig_19155521_6.txt","hipc_gene_sig_complete_19155521_6.txt"
"","hipc_gene_19155521_6","2009.02","hipc_gene_19155521_6","peripheral blood mononuclear cell","SLC43A1","20","SLC43A1","20","gene expression","negativelyly  correlated with","none","12","Months","time of vaccination (first dose)","antibody response","human Papillomavirus","","VO_0003156","","young adults (18-25)","","","19155521","2009","Suppl Table III","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701477/bin/NIHMS83712-supplement-Supplemetary_t.doc' target='_blank'>Supplemetary_t.doc</a>","Spearman Correlation of Gene Expression with Neutralizing Antibody Levels","N","https://www.ncbi.nlm.nih.gov/pubmed/?term=19155521","adults","18","25","years","6","161","19155521_6_161","hipc_gene_sig_19155521_6.txt","hipc_gene_sig_complete_19155521_6.txt"
"","hipc_gene_19155521_6","2009.02","hipc_gene_19155521_6","peripheral blood mononuclear cell","LEF1","20","LEF1","20","gene expression","negativelyly  correlated with","none","12","Months","time of vaccination (first dose)","antibody response","human Papillomavirus","","VO_0003156","","young adults (18-25)","","","19155521","2009","Suppl Table III","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701477/bin/NIHMS83712-supplement-Supplemetary_t.doc' target='_blank'>Supplemetary_t.doc</a>","Spearman Correlation of Gene Expression with Neutralizing Antibody Levels","N","https://www.ncbi.nlm.nih.gov/pubmed/?term=19155521","adults","18","25","years","6","161","19155521_6_161","hipc_gene_sig_19155521_6.txt","hipc_gene_sig_complete_19155521_6.txt"
"","hipc_gene_19155521_6","2009.02","hipc_gene_19155521_6","peripheral blood mononuclear cell","HPCAL1","20","HPCAL1","20","gene expression","negativelyly  correlated with","none","12","Months","time of vaccination (first dose)","antibody response","human Papillomavirus","","VO_0003156","","young adults (18-25)","","","19155521","2009","Suppl Table III","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701477/bin/NIHMS83712-supplement-Supplemetary_t.doc' target='_blank'>Supplemetary_t.doc</a>","Spearman Correlation of Gene Expression with Neutralizing Antibody Levels","N","https://www.ncbi.nlm.nih.gov/pubmed/?term=19155521","adults","18","25","years","6","161","19155521_6_161","hipc_gene_sig_19155521_6.txt","hipc_gene_sig_complete_19155521_6.txt"
"","hipc_gene_19155521_6","2009.02","hipc_gene_19155521_6","peripheral blood mononuclear cell","KRT5","20","KRT5","20","gene expression","negativelyly  correlated with","none","12","Months","time of vaccination (first dose)","antibody response","human Papillomavirus","","VO_0003156","","young adults (18-25)","","","19155521","2009","Suppl Table III","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701477/bin/NIHMS83712-supplement-Supplemetary_t.doc' target='_blank'>Supplemetary_t.doc</a>","Spearman Correlation of Gene Expression with Neutralizing Antibody Levels","N","https://www.ncbi.nlm.nih.gov/pubmed/?term=19155521","adults","18","25","years","6","161","19155521_6_161","hipc_gene_sig_19155521_6.txt","hipc_gene_sig_complete_19155521_6.txt"
"","hipc_gene_19155521_6","2009.02","hipc_gene_19155521_6","peripheral blood mononuclear cell","SORL1","20","SORL1","20","gene expression","negativelyly  correlated with","none","12","Months","time of vaccination (first dose)","antibody response","human Papillomavirus","","VO_0003156","","young adults (18-25)","","","19155521","2009","Suppl Table III","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701477/bin/NIHMS83712-supplement-Supplemetary_t.doc' target='_blank'>Supplemetary_t.doc</a>","Spearman Correlation of Gene Expression with Neutralizing Antibody Levels","N","https://www.ncbi.nlm.nih.gov/pubmed/?term=19155521","adults","18","25","years","6","161","19155521_6_161","hipc_gene_sig_19155521_6.txt","hipc_gene_sig_complete_19155521_6.txt"
"","hipc_gene_19155521_6","2009.02","hipc_gene_19155521_6","peripheral blood mononuclear cell","SNCA","20","SNCA","20","gene expression","negativelyly  correlated with","none","12","Months","time of vaccination (first dose)","antibody response","human Papillomavirus","","VO_0003156","","young adults (18-25)","","","19155521","2009","Suppl Table III","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701477/bin/NIHMS83712-supplement-Supplemetary_t.doc' target='_blank'>Supplemetary_t.doc</a>","Spearman Correlation of Gene Expression with Neutralizing Antibody Levels","N","https://www.ncbi.nlm.nih.gov/pubmed/?term=19155521","adults","18","25","years","6","161","19155521_6_161","hipc_gene_sig_19155521_6.txt","hipc_gene_sig_complete_19155521_6.txt"
"","hipc_gene_19155521_6","2009.02","hipc_gene_19155521_6","peripheral blood mononuclear cell","PLIN2","20","PLIN2","20","gene expression","negativelyly  correlated with","none","12","Months","time of vaccination (first dose)","antibody response","human Papillomavirus","","VO_0003156","","young adults (18-25)","","","19155521","2009","Suppl Table III","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701477/bin/NIHMS83712-supplement-Supplemetary_t.doc' target='_blank'>Supplemetary_t.doc</a>","Spearman Correlation of Gene Expression with Neutralizing Antibody Levels","N","https://www.ncbi.nlm.nih.gov/pubmed/?term=19155521","adults","18","25","years","6","161","19155521_6_161","hipc_gene_sig_19155521_6.txt","hipc_gene_sig_complete_19155521_6.txt"
"","hipc_gene_19155521_6","2009.02","hipc_gene_19155521_6","peripheral blood mononuclear cell","CFD","20","CFD","20","gene expression","negativelyly  correlated with","none","12","Months","time of vaccination (first dose)","antibody response","human Papillomavirus","","VO_0003156","","young adults (18-25)","","","19155521","2009","Suppl Table III","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701477/bin/NIHMS83712-supplement-Supplemetary_t.doc' target='_blank'>Supplemetary_t.doc</a>","Spearman Correlation of Gene Expression with Neutralizing Antibody Levels","N","https://www.ncbi.nlm.nih.gov/pubmed/?term=19155521","adults","18","25","years","6","161","19155521_6_161","hipc_gene_sig_19155521_6.txt","hipc_gene_sig_complete_19155521_6.txt"
"","hipc_gene_19155521_6","2009.02","hipc_gene_19155521_6","peripheral blood mononuclear cell","HS3ST1","20","HS3ST1","20","gene expression","negativelyly  correlated with","none","12","Months","time of vaccination (first dose)","antibody response","human Papillomavirus","","VO_0003156","","young adults (18-25)","","","19155521","2009","Suppl Table III","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701477/bin/NIHMS83712-supplement-Supplemetary_t.doc' target='_blank'>Supplemetary_t.doc</a>","Spearman Correlation of Gene Expression with Neutralizing Antibody Levels","N","https://www.ncbi.nlm.nih.gov/pubmed/?term=19155521","adults","18","25","years","6","161","19155521_6_161","hipc_gene_sig_19155521_6.txt","hipc_gene_sig_complete_19155521_6.txt"
"","hipc_gene_19155521_6","2009.02","hipc_gene_19155521_6","peripheral blood mononuclear cell","TNS1","20","TNS1","20","gene expression","negativelyly  correlated with","none","12","Months","time of vaccination (first dose)","antibody response","human Papillomavirus","","VO_0003156","","young adults (18-25)","","","19155521","2009","Suppl Table III","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701477/bin/NIHMS83712-supplement-Supplemetary_t.doc' target='_blank'>Supplemetary_t.doc</a>","Spearman Correlation of Gene Expression with Neutralizing Antibody Levels","N","https://www.ncbi.nlm.nih.gov/pubmed/?term=19155521","adults","18","25","years","6","161","19155521_6_161","hipc_gene_sig_19155521_6.txt","hipc_gene_sig_complete_19155521_6.txt"
"","hipc_gene_19155521_6","2009.02","hipc_gene_19155521_6","peripheral blood mononuclear cell","MZF1","20","MZF1","20","gene expression","negativelyly  correlated with","none","12","Months","time of vaccination (first dose)","antibody response","human Papillomavirus","","VO_0003156","","young adults (18-25)","","","19155521","2009","Suppl Table III","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701477/bin/NIHMS83712-supplement-Supplemetary_t.doc' target='_blank'>Supplemetary_t.doc</a>","Spearman Correlation of Gene Expression with Neutralizing Antibody Levels","N","https://www.ncbi.nlm.nih.gov/pubmed/?term=19155521","adults","18","25","years","6","161","19155521_6_161","hipc_gene_sig_19155521_6.txt","hipc_gene_sig_complete_19155521_6.txt"
"","hipc_gene_19155521_6","2009.02","hipc_gene_19155521_6","peripheral blood mononuclear cell","SRRM2","20","SRRM2","20","gene expression","negativelyly  correlated with","none","12","Months","time of vaccination (first dose)","antibody response","human Papillomavirus","","VO_0003156","","young adults (18-25)","","","19155521","2009","Suppl Table III","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701477/bin/NIHMS83712-supplement-Supplemetary_t.doc' target='_blank'>Supplemetary_t.doc</a>","Spearman Correlation of Gene Expression with Neutralizing Antibody Levels","N","https://www.ncbi.nlm.nih.gov/pubmed/?term=19155521","adults","18","25","years","6","161","19155521_6_161","hipc_gene_sig_19155521_6.txt","hipc_gene_sig_complete_19155521_6.txt"
"","hipc_gene_19155521_6","2009.02","hipc_gene_19155521_6","peripheral blood mononuclear cell","CHRNA7","20","CHRNA7","20","gene expression","negativelyly  correlated with","none","12","Months","time of vaccination (first dose)","antibody response","human Papillomavirus","","VO_0003156","","young adults (18-25)","","","19155521","2009","Suppl Table III","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701477/bin/NIHMS83712-supplement-Supplemetary_t.doc' target='_blank'>Supplemetary_t.doc</a>","Spearman Correlation of Gene Expression with Neutralizing Antibody Levels","N","https://www.ncbi.nlm.nih.gov/pubmed/?term=19155521","adults","18","25","years","6","161","19155521_6_161","hipc_gene_sig_19155521_6.txt","hipc_gene_sig_complete_19155521_6.txt"
"","hipc_gene_19155521_6","2009.02","hipc_gene_19155521_6","peripheral blood mononuclear cell","SPAG8","20","SPAG8","20","gene expression","negativelyly  correlated with","none","12","Months","time of vaccination (first dose)","antibody response","human Papillomavirus","","VO_0003156","","young adults (18-25)","","","19155521","2009","Suppl Table III","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701477/bin/NIHMS83712-supplement-Supplemetary_t.doc' target='_blank'>Supplemetary_t.doc</a>","Spearman Correlation of Gene Expression with Neutralizing Antibody Levels","N","https://www.ncbi.nlm.nih.gov/pubmed/?term=19155521","adults","18","25","years","6","161","19155521_6_161","hipc_gene_sig_19155521_6.txt","hipc_gene_sig_complete_19155521_6.txt"
